Skip to main content
Clinical Trials/NCT04108663
NCT04108663
Completed
Not Applicable

Lasting Amelioration of Deficient Cognitive Control by Transcranial Direct Current Stimulation (tDCS)-Enhanced Training

University Hospital Tuebingen1 site in 1 country173 target enrollmentApril 15, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cognitive Control
Sponsor
University Hospital Tuebingen
Enrollment
173
Locations
1
Primary Endpoint
Cognitive performance
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Cognitive control (CC) is an important prerequisite for goal-directed behaviour and often associated with dysfunctional prefrontal activity within the cortex. This can be ameliorated by non-invasive brain stimulation. In this randomised single-blind study we compare effects of transcranial direct current stimulation (tDCS) on CC in healthy subjects. The study includes 162 subjects who undergo a two-week (six sessions) training of cognitive control (adaptive paced auditory serial addition task, PASAT) supported by tDCS. Subjects are randomised to receive either concurrent anodal, cathodal, or sham tDCS with an intensity of 1 mA or 2 mA of their left (F3) or right (F4) PFC, resulting in eight stimulation groups. Stimulation effects on performance changes are compared to a sham control group.Changes in Affective state are measured by the positive and negative affect schedule (PANAS), possible transfer effects are assessed by the Eriksen Flanker task. Stability of effects is measured up to three months after the last intervention.

Registry
clinicaltrials.gov
Start Date
April 15, 2016
End Date
March 26, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christian Plewnia, MD

Doctor of Psychiatry and Psychotherapy

University Hospital Tuebingen

Eligibility Criteria

Inclusion Criteria

  • Healthy subjects
  • Right-handed (assessed by Edinburgh Handedness Inventory)
  • No other concurrent brain stimulation during participation
  • Proficient in German (min. CEFR level B)
  • Ability to strictly adhere to study timeline

Exclusion Criteria

  • Diagnosed neurological illnesses
  • Diagnosed psychiatric disorders
  • Achromatopsia
  • Metallic implants / tattoos on or near electrode sites
  • Consumption of tobacco to an equivalent of ten or more cigarettes per day
  • Prior participation in experiments involving the PASAT

Outcomes

Primary Outcomes

Cognitive performance

Time Frame: 2 to 14 weeks

Changes in performance in the PASAT (as assessed by number of correct trials within each PASAT session) due to the various tDCS interventions. All eight interventions will be compared to the sham group. Cognitive performance is modified by tDCS, which is applied through a multi-channel stimulator (DC-Stimulator MC, NeuroConn GmbH, Ilmenau, Germany; software version 1.3.8; two rectangular rubber electrodes (5 x 7 cm)).

Secondary Outcomes

  • Affective state(2 weeks)
  • Transfer effect(3 weeks)

Study Sites (1)

Loading locations...

Similar Trials